Boston Scientific Corp (NYSE:BSX) dropped 10% Wednesday after Chief Executive Mike Mahoney indicated that standalone Watchman heart implant procedures continue to decline and highlighted near-term ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-05-28 11:25:00

















